These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 15696844)

  • 1. Irritable bowel syndrome in general practice: an overview.
    Oberndorff-Klein Woolthuis AH; Brummer RJ; de Wit NJ; Muris JW; Stockbrügger RW
    Scand J Gastroenterol Suppl; 2004; (241):17-22. PubMed ID: 15696844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients suspected of irritable bowel syndrome--cross-sectional study exploring the sensitivity of Rome III criteria in primary care.
    Engsbro AL; Begtrup LM; Kjeldsen J; Larsen PV; de Muckadell OS; Jarbøl DE; Bytzer P
    Am J Gastroenterol; 2013 Jun; 108(6):972-80. PubMed ID: 23419383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How general practitioners manage patients with irritable bowel syndrome. Data from a German urban area.
    Franke A; Singer MV; Dumitraşcu DL
    Rom J Intern Med; 2009; 47(1):47-53. PubMed ID: 19886069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Rome criteria for the diagnosis of irritable bowel syndrome in primary care: a survey among European countries.
    Mujagic Z; Jonkers DMAE; Hungin APS; de Wit NJ; Wensaas KA; Palka M; Leeters V; Kruimel JW; Leue C; Masclee AAM; Muris JWM
    Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):651-656. PubMed ID: 28125426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosing irritable bowel syndrome: poor agreement between general practitioners and the Rome II criteria.
    Vandvik PO; Aabakken L; Farup PG
    Scand J Gastroenterol; 2004 May; 39(5):448-53. PubMed ID: 15180182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irritable bowel syndrome in France: quality of life, medical management, and costs: the Encoli study.
    Brun-Strang C; Dapoigny M; Lafuma A; Wainsten JP; Fagnani F
    Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1097-103. PubMed ID: 17998835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irritable bowel syndrome: the clinical approach.
    Adriani A; Ribaldone DG; Astegiano M; Durazzo M; Saracco GM; Pellicano R
    Panminerva Med; 2018 Dec; 60(4):213-222. PubMed ID: 30257542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doctor-patient interaction for irritable bowel syndrome in primary care: a systematic perspective.
    Dhaliwal SK; Hunt RH
    Eur J Gastroenterol Hepatol; 2004 Nov; 16(11):1161-6. PubMed ID: 15489576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of medical costs generated by IBS patients in primary and secondary care in the Netherlands.
    Flik CE; Laan W; Smout AJ; Weusten BL; de Wit NJ
    BMC Gastroenterol; 2015 Nov; 15():168. PubMed ID: 26612205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A positive diagnostic strategy is noninferior to a strategy of exclusion for patients with irritable bowel syndrome.
    Begtrup LM; Engsbro AL; Kjeldsen J; Larsen PV; Schaffalitzky de Muckadell O; Bytzer P; Jarbøl DE
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):956-62.e1. PubMed ID: 23357491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical management of irritable bowel syndrome: a clinical review.
    Almquist E; Törnblom H; Simrén M
    Minerva Gastroenterol Dietol; 2016 Mar; 62(1):30-48. PubMed ID: 26448307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using read codes to identify patients with irritable bowel syndrome in general practice: a database study.
    Harkness EF; Grant L; O'Brien SJ; Chew-Graham CA; Thompson DG
    BMC Fam Pract; 2013 Dec; 14():183. PubMed ID: 24295337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irritable bowel syndrome - from etiopathogenesis to therapy.
    Radovanovic-Dinic B; Tesic-Rajkovic S; Grgov S; Petrovic G; Zivkovic V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2018 Mar; 162(1):1-9. PubMed ID: 29358788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosing and managing irritable bowel syndrome with predominant diarrhoea in clinical practice: online survey among gastroenterologists and general practitioners.
    Casteels P; Kindt S
    Acta Gastroenterol Belg; 2024; 87(2):229-234. PubMed ID: 39210754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional bowel disorders in primary care: factors associated with health-related quality of life and doctor consultation.
    Lee V; Guthrie E; Robinson A; Kennedy A; Tomenson B; Rogers A; Thompson D
    J Psychosom Res; 2008 Feb; 64(2):129-38. PubMed ID: 18222126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of irritable bowel syndrome patients managed in primary and secondary care: the Episode IBS study.
    Smith GD; Steinke DT; Kinnear M; Penny KI; Pathmanathan N; Penman ID;
    Br J Gen Pract; 2004 Jul; 54(504):503-7. PubMed ID: 15239911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [ATTITUDES AND KNOWLEDGE OF GENERAL PRACTITIONERS ABOUT IRRITABLE BOWEL SYNDROME].
    Kelava I; Karabeg V; Špehar SS
    Acta Med Croatica; 2015 Nov; 69(4):245-52. PubMed ID: 29083559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of irritable bowel syndrome in the elderly.
    Kurniawan I; Kolopaking MS
    Acta Med Indones; 2014 Apr; 46(2):138-47. PubMed ID: 25053688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What general practitioners know about irritable bowel syndrome. Preliminary data from a Romanian province.
    Dumitrascu DL; David L; Singer M
    J Gastrointestin Liver Dis; 2006 Sep; 15(3):227-30. PubMed ID: 17013446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research.
    Fehnel SE; Ervin CM; Carson RT; Rigoni G; Lackner JM; Coons SJ;
    Value Health; 2017 Apr; 20(4):618-626. PubMed ID: 28408004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.